Augmenting Existing Normative Data for QbMobile in Healthy Children Aged 6-11 Years

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-60
SponsorQbtech AB

About this trial

The purpose of this study is to strengthen the normative QbMobile data for children and adolescents age 6-11 years to allow for a more robust and accurate representation when comparing a patient's QbMobile performance with the appropriate normative reference group.

Eligibility criteria

Qualifiers

Provide informed consent from parent/legal guardians and assent for all study participants for the QbMobile study;

Aged > 6 years and < 11 years old;

Have no documented or suspected current or lifetime diagnosis of ADHD;

Have adequate sensory and physical ability to complete QbMobile;

Disqualifiers

Intellectual disability designated by IQ<75;

Has a concurrent medical diagnosis that could significantly affect test performance such as brain injuries, Parkinson's disease, current epilepsy or active seizures, amyotrophic lateral sclerosis (ALS), multiple sclerosis, dementias (e.g. vascular dementia, Alzheimer disease), unmanaged psychiatric illness;

Has other conditions that could affect test performance (migraine or other types of severe headache, chronic or acute pain);

Substance use (e.g., alcohol, drugs) that may affect performance on the day of the tests.

Trial design

Treatments tested in this trial

  • Digital software application for cognitive performance and activity measurement (QbMobile, investigational device)

Treatment groups

150 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators